Ischemic peripheral neuropathy is a frequent, severe and irreversible complication of critical limb ischemia. Therapeutic angiogenesis may ameliorate vascular insufficiency and may also provide direct beneficial effects on neural integrity, indicating a new paradigm for the treatment of neuronal disorders (pages 405–413).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Eames,R.A. & Lange,L.S. Clinical and pathological study of ischaemic neuropathy. J. Neurol. Neurosurg. Psychiatry 30, 215–226 (1967).
Schratzberger, et al. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nature Med. 6, 405–413 ( 2000).
Kornowski,R., Fuchs,S., Leon,M.B. & Epstein,S.E. Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 101, 454–458 (2000).
Leung,D.W., Cachianes,G., Kuang,W.J., Goeddel,D.V. & Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306– 1309 (1989).
Senger,D.R. et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983–985 (1983).
Shweiki,D., Itin,A., Soffer,D. & Keshet,E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis . Nature 359, 843–845 (1992).
Losordo,D.W. et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800 –2804 (1998).
Baumgartner,I. et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [see comments]. Circulation 97, 1114–1123 (1998).
Aiello,L.P. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480–1487 ( 1994).
Casey,R. & Li,W.W. Factors controlling ocular angiogenesis . Am. J. Ophthalmol. 124, 521– 529 (1997).
Duh,E. & Aiello,L.P. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 48, 1899–1906 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aiello, L. Keeping in touch with angiogenesis. Nat Med 6, 379–381 (2000). https://doi.org/10.1038/74633
Issue Date:
DOI: https://doi.org/10.1038/74633
This article is cited by
-
Use of radioiodinated peptide Arg-Arg-Leu targeted to neovascularization as well as tumor cells in molecular tumor imaging
Chinese Journal of Cancer Research (2012)
-
The further study on radioiodinated peptide Arg-Arg-Leu targeted to neovascularization as well as tumor cells in molecular tumor imaging
Journal of Radioanalytical and Nuclear Chemistry (2011)